Stock prices are volatile due to different factors that are involved in the stock market, such as geopolitical tension, company earnings, and commodity prices, affecting stock price. Sometimes stock prices react to domestic uncertainty such as reserve bank policy, government policy, inflation, and global market uncertainty. The volatility estimation of stock is one of the challenging tasks for traders. Accurate prediction of stock price helps investors to reduce the risk in portfolio or investment. Stock prices are nonlinear. To deal with nonlinearity in data, we propose a hybrid stock prediction model using the prediction rule ensembles (PRE) technique and deep neural network (DNN). First, stock technical indicators are considered to identify the uptrend in stock prices. We considered moving average technical indicators: moving average 20 days, moving average 50 days, and moving average 200 days. Second, using the PRE technique-computed different rules for stock prediction, we selected the rules with the lowest root mean square error (RMSE) score. Third, the three-layer DNN is considered for stock prediction. We have fine-tuned the hyperparameters of DNN, such as the number of layers, learning rate, neurons, and number of epochs in the model. Fourth, the average results of the PRE and DNN prediction model are combined. The hybrid stock prediction model results are computed using the mean absolute error (MAE) and RMSE metric. The performance of the hybrid stock prediction model is better than the single prediction model, namely DNN and ANN, with a 5% to 7% improvement in RMSE score. The Indian stock price data are considered for the work.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.